Recently diagnosed with HIV? Click here

Positive Living December 2004–January 2005

Cover Story

One pill, once a day?

Positive Living article — Sunday, 19 December 2004

The HIV drug manufacturers Gilead Sciences, Bristol-Myers Squibb (BMS) and Merck have announced a joint venture to develop a single-pill, once-a-day HIV treatment. read more »

Tags: HIV treatments, multi-class formulations

News

Medicare, PBS changes

Positive Living article • Paul Kidd • 19 December 2004

From January 1, changes to Medicare rebates and Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. co-payments will have some people paying less to see their GP, but will also significantly increase prescription drug costs. read more »

Could a spoonful of sugar make the medicine go down?

Positive Living article • Kirsty Machon • 19 December 2004

German researchers believe a nucleoside extracted from sugar cane could be the key to preventing and even reversing cell damage from HIV drugs. read more »

Internet links positive women

Positive Living article • admin • 19 December 2004

The National Association of People Living With HIV/AIDS (NAPWHA) has set up an innovative project to link Australian positive women via the internet. read more »

Controversy over World AIDS Day launch

Positive Living article • Paul Kidd • 19 December 2004

AIDS advocates say they are disappointed at the failure of organisers to include any HIV-positive people in the official program for World AIDS Day in Canberra. read more »

Three steps forward

Positive Living article • Paul Kidd • 19 December 2004

In separate developments, scientists in Britain, the US and Germany have made discoveries about HIV which promise to significantly improve the effectiveness(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase II clinical trials gauge efficacy, and Phase III trials confirm it. of future treatments. read more »

Feature

A tale of two cities

Positive Living article • Paul Kidd • 19 December 2004

With major medical conferences in the United States and Scotland, November was a busy month for HIV medicine. PAUL KIDD reviews some key findings. read more »

Never say never

Positive Living article • Bernie Slagtman • 19 December 2004

The fusion inhibitor T-20 is presents some special challenges when travelling. Bernie Slagtman shares his tips for taking T-20 on the road. read more »

Good news stories

Positive Living article • David Menadue • 19 December 2004

The new year is upon us so I thought I’d look for a some good news stories to kick 2005 off on a positive note! Surprisingly I had little difficulty in finding examples of HIV-positive people who have fought a discriminatory policy or practice which worked against them because of their status—and who won out in the end. read more »

Undetectable

Positive Living article • Paul Kidd • 19 December 2004

Achieving undetectable viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. is the primary objective of anti-HIV therapy, but for some people it’s an unattainable goal. But now, as PAUL KIDD explains, there’s encouraging news for those who can’t quite get there. read more »

Regular

Positive Voices

Crossing the line

Positive Living article • Jason Appleby • 19 December 2004

Sometimes dealing with HIV means abandoning long-held dreams and changing your life to make room for the virusA small infective organism which is incapable of reproducing outside a host cell., writes Jason Appleby. read more »

What's Your Problem?

What's your problem?

Positive Living article • Dr Nick Medland • 19 December 2004

PL's resident medical expert, Dr Nick Medland, answers readers' letters about missing doses, starting treatments and sexually-transmitted infections. read more »

Backgrounder

Crocodile hunter

Positive Living article • Paul Kidd • 19 December 2004

There’s so much information out there about HIV/AIDS, espcially on the internet. How do you tell the good from the bad? read more »

Complementary Therapies

Beyond the barbs

Positive Living article • Jim Arachne • 19 December 2004

Peripheral neuropathy (PN) is a debilitating treatment side effectAn unwanted effect caused by the administration of drugs. Onset may be sudden or develop over time. and one of the common reasons for people stopping their anti-HIV medication. read more »

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

Positive Living is NAPWHA's national HIV treatments publication, published four times a year.

You can read PL on this website, subscribe to our free email version, or pick up a free copy in your local gay and lesbian community newspaper. If you'd rather receive PL through the post, we are happy to provide a free subscription to positive people anywhere in Australia.

Positive Living is distributed with generous assistance from Gilead Sciences and ViiV Healthcare.

Gilead and ViiV logos

Download PDF version

AttachmentSize
PDF of this issue1.52 MB